ERAS and breast neoplasm: As a conclusion, in this report we show that ERAS is expressed in a subset of breast tumors and demonstrate that ERAS expression in human normal mammary gland cells leads to a strong induction of EMT and to the development of tumoral and stem-cell features, which can be at least in part reverted by reactivation of miR-200c.